What is Advanced Pharma?
Advanced Pharma operates as a premier clinical research facility, specializing in both early and late-phase studies. With over five decades of combined Phase I expertise, the organization has successfully executed more than 150 clinical trials. Their research spans Phases I through IV, guided by experienced Physician Investigators. The facility is equipped with advanced diagnostic tools, including onsite FibroScan for liver diagnostics, which enhances their capabilities in liver-related research and pharmaceutical development. Advanced Pharma is committed to scientific excellence, ensuring a positive and respectful experience for all study participants.
How much funding has Advanced Pharma raised?
Advanced Pharma has raised a total of $429K across 2 funding rounds:
Debt
$150K
Debt
$279K
Debt (2020): $150K with participation from PPP
Debt (2021): $279K led by PPP
What's next for Advanced Pharma?
The recent major strategic investment in Advanced Pharma signals a pivotal moment for the company, likely enabling accelerated expansion of its research capabilities and the pursuit of new therapeutic areas. As a late-stage entity, this capital infusion is expected to support the scaling of ongoing trials, the development of novel research methodologies, and potentially strategic partnerships within the pharmaceutical industry. The company's focus on high-quality research and advanced diagnostics positions it for continued leadership in clinical development and pharmaceutical innovation.
See full Advanced Pharma company page
